Press Releases
EMA accepts Merck’s MAA for cladribine tablets in multiple sclerosis
Merck, a leading science and technology company announced that the EMA to request the company for marketing approval for its investigational Cladribine Tablets for the...
Press Releases
Biogen SB5 accepted for review by European Medicines Agency
The Marketing Authorization Application (MAA) for SB5, an adalimumab biosimilar candidate referencing Humira®1, has been accepted for review by the EMA. The MAA for SB5...
Press Releases
Regeneron and Sanofi announce approval of praluent (alirocumab) in Japan
Sanofi and Regeneron Pharmaceuticals, Inc. announced that the Ministry of Health, Labor and Welfare in Japan has granted marketing and manufacturing authorization for Praluent® (alirocumab)...
Press Releases
Abbott laboratories says U.S. FDA approves tecnis symfony intraocular lenses
Approval includes toric version of symfony iol for people with astigmatism lenses provide high-quality continuous vision so patients can see clearly at near, intermediate...
Press Releases
Health Canada approves Abbott’s Absorb Bioresorbable Stent
Revolutionary Device Made Of Naturally Dissolving Material, Similar To Dissolving Sutures Treats Coronary Artery Disease Like A Metallic Stent, But Then Disappears...
Press Releases
Dailies Total1 Multifocal contact lenses launched for presbyopia- Alcon
Alcon, the global leader in eye care and a division of Novartis, introduces Dailies Total1 Multifocal contact lenses for people with presbyopia. This innovative multifocal...
Press Releases
Boehringer Ingelheim and University of Dundee collaborate to develop new class of medicines
Collaboration aims to develop PROteolysis TArgeting Chimeric molecules (PROTACs) – a new therapeutic modality that is able to degrade proteins playing a central role...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.